Stem cell therapy for neurological disorders

Area of Science:

• Neuroscience
• Regenerative Medicine
• Clinical Trials

Background:

• Neurological diseases represent a significant global health burden with limited effective treatments.
• Current therapeutic options for neurological disorders are insufficient, and drug approval rates are low.
• Stem cell therapy presents a promising avenue, but requires further scientific and clinical validation.

Purpose of the Study:

• To provide an overview of stem cell applications in neurological disease.
• To describe the current clinical trial landscape and progress over the past decade.
• To highlight the potential and challenges of stem cell-based therapies for neurological conditions.

Main Methods:

• Review of stem cell types used in neurological disease treatment (neural, hematopoietic, mesenchymal, ESCs, iPSCs).
• Analysis of the clinical trial landscape for stem cell therapies in neurological disorders.
• Identification of neurological indications currently in clinical development.

Main Results:

• Over 200 clinical studies involving stem cell therapy for neurological diseases are registered.
• Multiple sclerosis, stroke, and spinal cord injuries are the most common indications in clinical trials.
• Seventeen neurological indications are in clinical development, but few have reached pivotal randomized trial stages.

Conclusions:

• Stem cell therapy holds promise for treating neurological diseases, but requires further evidence-based validation.
• The majority of registered clinical studies are in early phases, with limited progression to large-scale pivotal trials.
• Future research and robust clinical trial data are essential for the mainstream application of stem cell therapies in neurology.